• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    MW Life Sciences

    K-Tube Technologies

    Medbio LLC

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.

    maxon

    Qosina Corp.

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Compliance with Medical Product Shortage Reporting Requirements During the COVID-19 Pandemic

    A reminder of what manufacturers should keep in mind during this turbulent time.

    Veleka Peeples-Dyer and Khelin Aiken, Baker McKenzie04.02.20
    Responding to and mitigating the impact of the COVID-19 pandemic has catapulted its way to the top of every business operation consideration in each industry and the global market in general. One of the more vulnerable operations for the life sciences industries we anticipate will continue to require adept and innovative efforts to mitigate impact is the medical product supply chain. Disruptions to medical product supply will not only affect public health, but it has significant burden on the manufacturer as well.
     
    Notably, the consequence of supply chain interruptions from a compliance perspective vary slightly, depending on the type of product and its indication. Human drug products and medical device products have different requirements for reporting supply chain disruptions, and the impact of COVID-19 has cast a bright light on this inequity. Compliance with reporting requirements is important during the ongoing pandemic.
     
    Medical Product Shortage Reporting Requirements
    The Federal Food Drug and Cosmetic Act requires manufacturers of a drug product that is life supporting, life sustaining, or intended for use in the prevention or treatment of a debilitating disease or condition that is not a radio pharmaceutical, including any such drug used in emergency medical care or during surgery, to report supply chain disruptions at least six months prior to the interruption, or if not possible, as soon as practicable.
     
    As is the case with some drug products, medical devices can be life supporting and life sustaining, posing a risk to public health if essential care for patients is disrupted. No similar reporting requirements for shortages of medical device products exist. Nevertheless, the FDA advises medical device/supply manufacturers to report shortages to the Center for Device and Radiologic Health (CDRH). It also tracks shortages and supply issues for such products. Manufacturers are encouraged to respond to FDA’s requests about potential supply chain disruption so the agency can take steps to help support awareness of potential disruption of access to critical medical products. Medical device manufacturers may report potential supply chain disruptions to the FDA’s device shortages mailbox at deviceshortages@fda.hhs.gov.
     
    Medical Product Shortage Compliance Vulnerabilities
    As early as late January, the FDA began reaching out to manufacturers to remind them of their legal reporting requirements for anticipated supply chain disruption in light of COVID-19. Since all active pharmaceutical ingredients (API), certain raw materials, excipients, components of medical devices, and finished products must be manufactured in FDA-approved and inspected facilities, identifying an alternative supplier and scaling up for inspection and approval is complicated. In many cases, a supplier of APIs or other components may be single- or limited-source.
     
    Initially, the FDA asked manufacturers to direct their supply chain inquiry to APIs and other components manufactured in China. This advisory was borne out of the FDA’s identification in late February of nearly 20 drug products with ingredients sourced from China, where COVID-19 severely impacted production. However, with the rapid spread of COVID-19, supply chain disruption concerns are no longer limited to China but have expanded globally. In fact, India’s recent curtailment of the export of 26 APIs may continue to increase vulnerabilities in manufacturers’ supply chains.
     
    Manufacturers typically forecast their supply through firm forecasting for a certain period (generally 12 months, depending on the drug product), and distributors have certain limitations on the amount of products they can hold in their warehouses. Distributors play a key role in the supply chain and can assist manufacturers in carefully assessing the demand for medical products. Given the rapid spread of COVID-19 and its impact on the industry, it is anticipated that manufacturers’ ability to provide advance notice of supply chain disruption may be significantly hampered.
     
    Key Takeaway
    It is vital for manufacturers of market-critical drug products to survey their supply chain and current available product supply to ensure compliance with reporting requirements. Further, while FDA inspections of manufacturing facilities in China are currently not taking place, the FDA has increased import sampling and screening in order to continue monitoring product quality. Supply chain compliance efforts must be nimble and respond to the shift in FDA monitoring efforts.
     
    As in past instances of worldwide disturbances, COVID-19 has unveiled the vulnerabilities of the medical product supply chain. It has highlighted the industry’s reliance on a complex system of import and export regulations, skilled workers, the availability of raw materials, API, and manufacturing outside of the US, and dependence on contract manufacturing organizations and other third party vendors located outside of the US. Even in the absence of a pandemic, medical product shortages occur for a variety of reasons, including quality issues and various other supply-chain-related delays. The full impact of COVID-19 is yet to be realized.

    The FDA maintains a list of drug shortages: at https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm.

    Update (April 7)
    The U.S. Congress deployed significant and extensive countermeasures in passing the CARES Act on March 27, 2020. Urgently signed into federal law that same day, the Coronavirus Aid, Relief, and Economic Security Act, or "CARES" Act, addresses a wide variety of issues, including drug and medical device shortages. In relevant part to this article, the CARES Act amended the Food, Drug and Cosmetic Act to aim to further mitigate drug shortages and prevent medical device shortages.
     
    Preventing Medical Device Shortages
    The FDCA amended to require that manufacturers of devices (i) deemed critical to the public health during a public health emergency, including devices that are life supporting, life sustaining, or intended for use in emergency medical care or during surgery; or (ii) for which it is determined that information on potential meaningful supply disruptions of such device is needed during or in advance of a public health emergency, provide notice of (i) permanent discontinuance in manufacture of the device (except for discontinuances as a result of an approved modification), or (ii) an interruption of the manufacture of the device that is likely to lead to a meaningful disruption in the supply of the device in the United States. (Section 3121)
     
    Mitigating Emergency Drug Shortages
    The CARES Act now requires the Secretary to not only expedite but also prioritize (i) the review of drug applications or supplements to such drug applications that could help mitigate or prevent a shortage; or (ii) the inspection or reinspections of an establishment that could help mitigate or prevent a drug shortage. (Section 3111)
     
    The Federal Food, Drug and Cosmetic Act is amended to require that manufacturers provide the FDA with advance notice of a shortage of any drug that is deemed critical to the public health during a public health emergency or any discontinuation or interruption in the supply of such drugs or its' active pharmaceutical ingredients. (Section 3112)


    Veleka Peeples-Dyer is chair, North America FDA Practice Group for Baker McKenzie. She brings more than 20 years of strategic and practical business and legal counsel to a wide span of biopharmaceutical companies, advising on FDA regulatory and compliance matters, including over 15 years of senior in-house counsel experience in leading biopharmaceutical companies. Peeples-Dyer’s practice provides full coverage for clients, including, but not limited to, clinical trials and good clinical practices (GCP); current good manufacturing practices (cGMP), including quality systems and quality management programs; pharmacovigilance; advertising and promotion; licensing, development and collaboration agreements; and compounding and compliance and enforcement, including assistance with FDA 483 audits, responses to warning letters and assistance with corrective and preventative actions (CAPAs) and other FDA enforcement actions.
     
    Khelin N. Aiken practices in the area of U.S. Food and Drug Administration regulatory and compliance law. She leverages her deep understanding of the U.S. Food Drug & Cosmetic Act, U.S. Public Health Service Act, and their implementing regulations along with her prior experience at the U.S. Food and Drug Administration (FDA) to help clients develop and achieve their strategic business objectives. Aiken focuses her practice on leading and counseling life sciences companies from product development through the product life cycle, with a particular focus on therapeutic product development plans and marketing applications for prescription drugs, including therapeutic biologics and generics.
    Related Searches
    • Materials
    • clinical trials
    • supply chain
    • Manufacturing

    Related Online Exclusives

    • Electronics
      EMS

      EMS' Engineering Resources Increasingly in Demand

      Unpredictable demand, the need to reduce costs, and shorter production lead times driving companies to seek earlier interaction with product engineers.
      Michael Barbella, Managing Editor 04.20.21

    • Electronics
      Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

      Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

      Devices with high-speed data capabilities and high-resolution video must be rugged enough to withstand OR environment and harsh sterilization methods.
      Michael Barbella, Managing Editor 04.15.21

    • Electronics
      EMS Providers Valued for Product Customization, Medical Certification Expertise

      EMS Providers Valued for Product Customization, Medical Certification Expertise

      maxon has increased its service offering over the last few years and is collaborating closely with medtech firms for their electronics needs.
      Michael Barbella, Managing Editor 04.12.21


    • Software & IT
      Three Future Trends and Opportunities in Quality Assurance

      Three Future Trends and Opportunities in Quality Assurance

      As regulated companies, medical device firms must stay abreast of the latest developments to ensure they adopt new protocols to maintain quality assurance.
      David Jensen, Staff Writer, MasterControl 04.09.21

    • Software & IT
      Adopting a Data-Driven Quality Model

      Adopting a Data-Driven Quality Model

      Employing a data-driven quality model helps you apply quality processes more holistically throughout the organization.
      David Jensen, Staff Writer, MasterControl 04.09.21

    • Software & IT
      Digital Transformation for Quality and Manufacturing

      Digital Transformation for Quality and Manufacturing

      The pandemic has illustrated the importance of a transition to digital solutions for medical device and other life sciences manufacturers.
      Jon Beckstrand, CEO, MasterControl 04.08.21


    • Cardiovascular
      Digging into the Cardiac Arrhythmia Monitoring Device Market

      Digging into the Cardiac Arrhythmia Monitoring Device Market

      The overall market is set to reach an annual valuation of $9 billion by 2026.
      Saloni Walimbe, Research Content Developer, Global Market Insights 04.08.21

    • Cardiovascular
      Cardiovascular Device Market Expands to Tackle Higher Disease Burden

      Cardiovascular Device Market Expands to Tackle Higher Disease Burden

      The market is likely to exceed a valuation of $10 billion by 2027.
      Vinisha Joshi, Research Content Developer, Global Market Insights 04.01.21

    • Electronics
      Talented Labor Pool a Challenge for EMS Providers

      Talented Labor Pool a Challenge for EMS Providers

      Workers skilled in electrical wiring and installation in medical products can be difficult to find.
      Michael Barbella, Managing Editor 03.31.21


    • Diagnostics
      Diagnosing the IVD Market: An Interview with TEAM Technologies

      Diagnosing the IVD Market: An Interview with TEAM Technologies

      Chief revenue officer Steve Lents discusses the in-vitro diagnostic market and manufacturing rapid antigen POC COVID-19 tests.
      Sam Brusco, Associate Editor 03.30.21

    • Why Is Manufacturing Demand Increasing for IV Bags?

      Why Is Manufacturing Demand Increasing for IV Bags?

      Many types and sizes of IV bags are in short supply, putting a strain on the industry.
      Emily Newton, Editor-in-Chief, Revolutionized 03.30.21

    • Software & IT
      Using Quality as an Advantage in 2021

      Using Quality as an Advantage in 2021

      Report finds despite pandemic, 79 percent of medical device professionals expect modest or strong revenue growth in 2021.
      Jon Speer, Founder, Greenlight Guru 03.25.21


    • Software & IT
      5 Ways Manufacturers Can Improve IoMT Device Security

      5 Ways Manufacturers Can Improve IoMT Device Security

      Manufacturers cannot make development and security mistakes with IoMT devices.
      Emily Newton, Editor-in-Chief, Revolutionized 03.23.21

    • Software & IT
      Three Reasons Automation and Training Are Essential in Your MDQMS

      Three Reasons Automation and Training Are Essential in Your MDQMS

      Having the proper tools in place to ensure all training activities are occurring when and how they should is critical to quality.
      Jon Speer, Founder, Greenlight Guru 03.15.21

    • Four Ways Remote Freelance Experts Can Help Medtech

      Four Ways Remote Freelance Experts Can Help Medtech

      Changes in the regulatory landscape and working-from-home scenarios reduce the degree of change when working with remote consultants.
      Ramya Sriram, Digital Content Manager, Kolabtree 03.15.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Device Designed To Permanently Replace Failing Human Hearts
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login